Rheumatology
-
Does Biological Therapy Protect against Severe COVID-19?
This article has 14 authors:Reviewed by ScreenIT
-
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
This article has 15 authors:Reviewed by ScreenIT
-
A COVID-19 outbreak in a rheumatology department upon the early days of the pandemic
This article has 13 authors:Reviewed by ScreenIT
-
Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents
This article has 11 authors:Reviewed by ScreenIT
-
Concerns about disease management and psychological stress in SAPHO patients during the COVID-19 epidemic
This article has 6 authors:Reviewed by ScreenIT
-
COVID-19 and patients with immune-mediated inflammatory diseases undergoing pharmacological treatments: a rapid living systematic review
This article has 13 authors:Reviewed by ScreenIT
-
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
This article has 20 authors:Reviewed by ScreenIT
-
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
This article has 62 authors:Reviewed by ScreenIT
-
Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India
This article has 5 authors:Reviewed by ScreenIT
-
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
This article has 4 authors:Reviewed by ScreenIT